Target intelligence / Profile preview

Lon peptidase 1, mitochondrial (LonP1)

Target
LonP1
Molecular classification
Enzyme, ATP-dependent protease, Mitochondrial matrix protein, AAA+ protein family (ATPases Associated with diverse cellular Activities)
01

Overview

Lon peptidase 1, mitochondrial (LonP1) is an ATP-dependent serine protease of the mitochondrial matrix, responsible for proteolytic removal of misfolded or damaged proteins, ensuring maintenance of mitochondrial protein homeostasis[1][2][3][4]. It also exhibits chaperone-like activity and binds mitochondrial DNA, playing direct roles in mitochondrial DNA replication and gene expression regulation, including the degradation of TFAM, to maintain mtDNA/TFAM ratios and support mitochondrial biogenesis[1][3]. Disruption or dysregulation of LonP1 activity is linked to multiple human diseases—cancer, neurodegeneration, cardiovascular, and heritable mitochondrial disorders—and LonP1 is under investigation as a therapeutic target[2][3][4]. High expression or mutation can serve as a disease biomarker; however, LonP1 is essential and loss-of-function is not tolerated in mammals[3].\nStructurally, human LONP1 contains substrate recognition, ATPase, and proteolytic domains, and operates as a homohexameric complex, with advanced conformational regulation depending on both substrate and nucleotide binding[1][4].

Other names
Lon protease homolog, mitochondrialLon protease 1LONP1AAA+ Lon proteasePIM1 in yeast (ortholog)La in bacteria (ortholog)
02

Mechanism of action

Protease inhibition (prevents degradation of specific mitochondrial proteins, alters protein quality control)\nModulation of mitochondrial function by stabilizing or destabilizing mitochondrial proteostasis and metabolism[2][4]\nMetabolic reprogramming (by influencing the fate of pyruvate and mitochondrial energy balance)[2]

03

Biological functions

Mitochondrial protein quality control (proteolysis of misfolded/damaged proteins)Chaperone activity (facilitates folding, assembly of mitochondrial complexes)Regulation of mitochondrial DNA replication/transcription (DNA-binding and TFAM degradation)Regulation of mitochondrial metabolism, including metabolic reprogramming (PDK4 degradation, MPC1 degradation, influence on pyruvate handling)Cellular stress response
04

Disease associations

Cancer (including prostate and others)Neurodegenerative diseaseCardiovascular disease (e.g., in heart muscle, cardiac mitochondria)Mitochondrial diseasesAging processOther metabolic disorders (via mitochondrial dysfunction)
05

Safety considerations

Potential for mitochondrial toxicity (since LONP1 is essential for mitochondrial function, inhibition may cause severe dysfunction)Embryonic lethality from complete loss (critical for survival; knockout is fatal early in development)Broad tissue expression, especially in energy-demanding organs, implies off-target effects risk
06

Interacting drugs

Bortezomib (peptidomimetic active site inhibitor used in structural and mechanistic studies)

1 more in the full profile.

07

Biomarkers

LONP1 expression level (used in studies of cancer, aging, mitochondrial disease risk or progression)TFAM/mtDNA ratio (reflects regulation of mitochondrial DNA metabolism)

Beyond the preview

Go deeper on Lon peptidase 1, mitochondrial (LonP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lon peptidase 1, mitochondrial (LonP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call